Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:41 PM
Ignite Modification Date:
2025-12-24 @ 10:41 PM
NCT ID:
NCT00136435
Eligibility Criteria:
Inclusion Criteria:
* Patients must have pathologically documented acute lymphoblastic leukemia, excluding mature B-cell ALL.
* No prior therapy for leukemia with the following exceptions:
* up to one week of steroids;
* emergent leukapheresis;
* emergency treatment for hyperleukocytosis with hydroxyurea;
* cranial RT for CNS leukostasis (one dose only);
* emergent radiation therapy to the mediastinum.
* Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2.
* Between the ages of 18 to 50 years.
Exclusion Criteria:
* Uncontrolled active infection.
* Pregnancy or nursing mothers.
* Prior history of pancreatitis.
* Prior history of a cerebrovascular accident or hemorrhage.
* Evidence of infection with the human immunodeficiency virus.
* Active psychiatric or mental illness making informed consent or careful clinical follow-up unlikely.
* The treating physician should consider all relevant medical and other considerations when deciding whether this protocol is appropriate for a particular patient.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT00136435
Study Brief:
Protocol Section:
NCT00136435